Mechanism of Hanshi Bi granules in the treatment of ankylosing spondylitis based on network
pharmacology

doi:10.3969/j.issn.2095-4344.2437

Abstract

Abstract:

BACKGROUND: Hanshi Bi granule has been used to treat ankylosing spondylitis in the clinic, but the pharmacological mechanism B is still unclear.

OBJECTIVE: To screen the compound and drug targets of Hanshi Bi granules based on network pharmacology, and construct a compound-target network to systematically investigate the pharmacological mechanism for treating ankylosing spondylitis.

METHODS: The compounds and drug targets of Hanshi Bi granules were collected from TCMSP database. Ankylosing spondylitis targets were from DRUGBANK, GeneCards, Home-OMIM-NCBI, and PALM-IST databases. The obtained drug targets and disease targets were corrected by Uniprot database and common genes were obtained using Draw Venn Diagrams analysis tool. PPI analysis was performed on the common gene in combination with the STRING database and Cytoscape 3.6.1. GO enrichment analysis and KEGG pathway enrichment analysis were performed on the common gene by using Cytoscape 3.6.1 plugin ClueGO.

RESULTS AND CONCLUSION: (1) Totally 69 active ingredients and 142 drug targets were obtained from TCMSP, and 595 ankylosing spondylitis targets were obtained using DRUGBANK, GeneCards, Home-OMIM-NCBI, and PALM-IST databases. (2) Using the Draw Venn Diagrams tool to analyze all targets, 39 common genes were obtained. Through PPI analysis, tumor necrosis factor, interleukin-6 and prostaglandin-in-peroxidase 2 were highly connected in the PPI network. (3) Through GO enrichment analysis, it mainly involved biological functions such as regulation of reactive oxygen metabolism, fatty acid metabolism, acute inflammatory reaction, neurotransmitter biosynthetic process, and metabolism of arachidonic acid. (4) Through KEGG pathway enrichment analysis, it mainly involved in AGE-RAGE signaling pathway, fluid shear stress and atherosclerosis, interleukin-17 signaling pathway, nuclear factor-κB signaling pathway, tumor necrosis factor signaling pathway, and Toll-like receptor signaling pathway. (5) This study preliminarily predicts the pharmacological mechanism underlying the treatment of ankylosing spondylitis with Hanshi Bi granules, and provides new ideas for secondary development of old drugs and experimental research.

Key words: ankylosing spondylitis, targets, network pharmacology, signaling pathway, Hanshi Bi granules

CLC Number:

Wang Zhuo, Shi Zhongfeng, Wang Fengyun, Li Weidong, Han Liang. Mechanism of Hanshi Bi granules in the treatment of ankylosing spondylitis based on network pharmacology[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(11): 1738-1744.

Figures/Tables 10

References

[1] 刘彧.强直性脊柱炎免疫遗传学发病机制的研究进展[J].中国临床医学, 2019,26(1):117-121.
[2] 张莉,沈海丽.老年强直性脊柱炎患者临床治疗及生活质量现况分析[J].中国地方病防治杂志,2018,33(2):177-178.
[3] 顾春芳,仇雅云,汤悦煦.强直性脊柱炎患者生活质量影响因素分析[J].中国医学前沿杂志(电子版),2017,9(10):145-148.
[4] LORIES RJ, HAROON N, Evolving concepts of new bone formation in axial spondyloarthritis: Insights from animal models and human studies. Best Pract Res Clin Rheumatol.2017;31(6): 877-886.
[5] 王田玲,徐亮.强直性脊柱炎骨桥形成与炎症关系的研究进展[J].中国临床药理学与治疗学,2015,20(1):101-105.
[6] LI X,WANG J,ZHAN Z,et al. Inflammation Intensity-Dependent Expression of Osteoinductive Wnt Proteins Is Critical for Ectopic New Bone Formation in Ankylosing Spondylitis.Arthritis Rheumatol. 2018 70(7):1056-1070.
[7] 杜天信,韩新峰,高书图.寒湿痹颗粒治疗寒湿痹阻型风湿病的效果分析[J].中国临床康复,2006,10(7):148-150.
[8] 王承德,姜泉,冯兴华,等.寒湿痹颗粒治疗风湿病寒湿痹阻证临床研究[J].中国中医急症,2008,17(2):175-177.
[9] 庞红梅.寒湿痹颗粒治疗类风湿关节炎､强直性脊柱炎和膝骨关节炎中医辨证属寒湿痹阻证的临床疗效[J].中医临床研究,2014,6(26):87-88.
[10] 杜天信,韩新峰,高书图.寒湿痹颗粒治疗寒湿痹阻型风湿病的临床观察——附375例报告[J].中医正骨,2002,14(3):10-12.
[11] 陈佩虹,甘丽,辛增辉,等.寒湿痹片抑制大鼠滑膜增生及相关机制研究[J].中国实验方剂学杂志,2009,15(11):73-75.
[12] 陈育尧,佟丽,吴启富,等.寒湿痹片对类风湿性关节炎模型大鼠踝关节组织病理改变的影响[J].浙江中西医结合杂志,2010,20(1):12-14.
[13] 朱梓铭,张因彪,郑景辉,等.基于网络药理学探究苓桂术甘汤治疗慢性心力衰竭的作用机制[J].临床心血管病杂志, 2019,35(2):154-161.
[14] HAREL A, INGER A, STELZER G, et al.GIFtS: annotation landscape analysis with GeneCards. Bmc Bioinformatics.2009;10(1):348-348.
[15] 叶清,李俊年,杨冬梅,等.植物槲皮素对东方田鼠免疫功能的影响[J].兽类学报,2019,39(1):77-83.
[16] 尧荣凤,李智,许国祥,等.中药活性成分抗自身免疫性关节炎作用的研究[J].中国骨与关节损伤杂志,2015,30(8):859-862.
[17] YUAN Z, MIN J, ZHAO Y, et al. Quercetin rescued TNF-alpha-induced impairments in bone marrow derived mesenchymal stem cell osteogenesis and improved osteoporosis in rats.Am J Transl Res. 2018;10(12):4313-4321.
[18] 贾庆运,王拥军,梁倩倩,等.槲皮素对小鼠胶原诱导性关节炎症的影响[J].中国骨质疏松杂志,2018,24(9):1175-1179.
[19] 马纳,李亚静,范吉平.槲皮素药理作用研究进展[J].辽宁中医药大学学报, 2018,20(8):221-224.
[20] 范轶鑫,刘海姣,李艺璇,等.槲皮素抑制脊髓小胶质细胞基质金属蛋白酶的表达改善术后疼痛的机制研究[J].中国药科大学学报, 2017,48(3): 343-347.
[21] 晁杲,廖圣宝,周静,等.异鼠李素抗骨质疏松作用及机制探讨[J].中国医院药学杂志,2016,36(17):1456-1460.
[22] 刘威良,姬昱,黄艾祥.β-谷甾醇的研究及开发进展[J].农产品加工,2019(1): 77-82.
[23] 肖志彬,贾韩学,刘小雷.β-谷甾醇药理活性的研究现状[J].世界最新医学信息文摘,2015,15(8):66-68.
[24] 张玲玲,魏伟.治疗自身免疫病药物研究进展[J].中国药理学通报,2019, 35(2):149-156.
[25] 李艳,孙文星,徐春瑛,等.NCOA2核心启动子甲基化分析及其与肾周和皮下脂肪组织差异表达的关系[J].南京农业大学学报, 2014,37(4):131-136.
[26] 倪海键,史冬泉,蒋青.CALM1基因及钙调素与骨关节炎[J].国际骨科学杂志,2008,(1):43-45.
[27] 乔丹丹,罗林.热休克蛋白90与肿瘤的生物学特性[J].云南医药,2016, 37(6):676-679.
[28] 周熹. CALM1/CALM2基因多态性与青少年特发性脊柱侧凸遗传易感性的关联性研究[D]. 北京:北京协和医学院,2009.
[29] 曹青青,傅照华.TNF-α与IL-1β对膝骨性关节炎的影响及展望[J].世界最新医学信息文摘,2017,17(58):37-38.
[30] RABELO CF, BAPTISTA TSA, PETERSEN LE, et al. Serum IL-6 correlates with axial mobility index (Bath Ankylosing Spondylitis Metrology Index) in Brazilian patients with ankylosing spondylitis.Open Access Rheumatol.2018;10: 21-25.
[31] 艾香艳,赵福涛,王艳玲.血清肿瘤坏死因子-α在老年痛风性关节炎中的变化特点及意义[J].老年医学与保健,2019,25(1):21-42.
[32] HARRIS RE, CASTO BC, HARRIS ZM.Cyclooxygenase-2 and the inflammogenesis of breast cancer.World J Clin Oncol. 2014;5(4): 677-692.
[33] LALIER L, PEDELABORDE F, BRAUD C, et al.Increase in intracellular PGE2 induces apoptosis in Bax-expressing colon cancer cell.BMC Cancer.2011;11(1):153.
[34] YANG S, GAO Q, JIANG W.Relationship between tumour angiogenesis and expression of cyclo-oxygenase-2 and vascular endothelial growth factor-A in human renal cell carcinoma.J Int Med Res. 2015;43(1):110-117.
[35] 刘莹,朱超,刘娟芳.活性氧与慢性神经病理性疼痛研究进展[J].中华神经外科疾病研究杂志,2014,13(4):382-384.
[36] 代喆,季振中,徐焱成.长链脂肪酸通过GPR120对脂肪细胞炎症、内质网应激及胰岛素信号分子的影响[J].中日友好医院学报,2014,28(4): 222-233.
[37] 宋俊垚.从JAK/STAT信号通路调控Th17分化探索补肾、清热､活血法干预强直性脊柱炎炎症分子机制[D].北京:北京中医药大学,2016
[38] 曹溆,张克勤.损伤相关分子模式与器官移植[J].中国免疫学杂志,2017, 33(11):1755-1760.
[39] 杨秀颖,张莉,陈熙,等.2型糖尿病周围神经病变机制研究进展[J].中国药理学通报,2016,32(5):598-602.
[40] BIERHAUS A, HUMPERT PM, MORCOS M, et al. Understanding RAGE, the receptor for advanced glycation end products.J Mol Med (Berl). 2005;83(11):876-886.
[41] 曹永平,吴浩.骨细胞与应力信号传导[J].中华骨质疏松和骨矿盐疾病杂志, 2012,5(4):237-246.
[42] 杨屹羚,张鹏,江凌勇.流体剪应力在骨髓基质干细胞成骨向分化中作用机制的研究进展[J].医用生物力学,2018,33(4):378-382.
[43] 秦臻,张彦燕,韦正新,等.当归补血汤在流体剪切应力环境中对内皮细胞功能的影响[J].北京中医药大学学报, 2018,41(8):630-635.